STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer, and marketer of the EVO family of Implantable Collamer® lenses ...
STAAR Surgical Company , a leading developer, manufacturer, and marketer of the EVO family of Implantable Collamer® lenses (EVO ICLtm) for myopia, astigmatism and presbyopia, is proud to announce a ...
EVO ICL has been a procedure that changed my ... The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018: 12: 2427-2438. About STAAR Surgical STAAR ...
With the increasing demand for vision correction options like EVO ICL, which offers an alternative to LASIK for patients seeking clear vision without glasses or contact lenses, Porter ...
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICLâ„¢) for ...
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICLâ„¢) for ...